title: Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system.
abstract: BK polyomavirus (BKPyV) is a known kidney tropic virus that has been detected at high levels in HIV-associated salivary gland disease (HIV-SGD), one of the most important AIDS associated oral lesions. BKPyV has been detected in HIV-SGD patient saliva and replicates in salivary gland cells in vitro. BKPyV antivirals are currently in wide use to guard against BKPyV mediated organ rejection in kidney transplant recipients. The goal of this study was to investigate the inhibitory effects of three such antiviral agents, Ciprofloxacin, Cidofovir, and Leflunomide in BKPyV infected salivary gland cells. Human salivary gland cells, and Vero cells, were infected with BKPyV, treated with antiviral drugs and assessed for BKPyV gene expression and viral replication for up to 5 days post infection. The kinetics of BKPyV replication were different in salivary gland cells compared to kidney cells. Ciprofloxacin and Cidofovir had minimal effect on metabolic activity and host cell DNA replication, however, cell toxicity was detected at the protein level with Leflunomide treatment. Ciprofloxacin decreased BKV T Ag and VP1 mRNA expression by at least 50% in both cell types, and decreased T Ag protein expression at days 3 and 4 post infection. A 2.5-4 log decrease in intracellular DNA replication and a 2-3 log decrease in progeny release were detected with Ciprofloxacin treatment. Cidofovir and Leflunomide also inhibited BKPyV gene expression and DNA replication. The three drugs diminished progeny release by 30-90% and 2- to 6-fold decreases in infectious virus were detected post drug treatment by fluorescence focus assay. Additionally, three clinical BKPyV isolates were assessed for their responses to these agents in vitro. Cidofovir and Leflunomide, but not Ciprofloxacin treatment resulted in statistically significant inhibition of BKPyV progeny release from salivary gland cells infected with HIVSGD BKPyV isolates. All three drugs decreased progeny release from cells infected with a transplant derived viral isolate. In conclusion, treatment of human salivary gland cells with each of the three drugs produced modest decreases in BKPyV genome replication. These data highlight the need for continued studies to discover more effective and less toxic drugs that inhibit BKPyV replication in salivary gland cells.
authors: Department of Dental Research, School of Dentistry, University of North Carolina at Chapel Hill, United States.
authors: Liesl K
authors: LK
authors: Jeffers-Francis
authors: Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, United States.
authors: Raquel
authors: R
authors: Burger-Calderon
authors: Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, United States; Department of Dental Research, School of Dentistry, University of North Carolina at Chapel Hill, United States; Department of Dental Ecology, School of Dentistry, University of North Carolina at Chapel Hill, United States. Electronic address: cyriaquj@dentistry.unc.edu.
authors: Jennifer
authors: J
authors: Webster-Cyriaque
mesh_terms: D000818:Animals; D000957:Antigens, Viral, Tumor / Q000032:analysis; D000998:Antiviral Agents / Q000494:pharmacology*; D001739:BK Virus / Q000187:drug effects* / Q000502:physiology; D002478:Cells, Cultured; D000077404:Cidofovir; D002939:Ciprofloxacin / Q000494:pharmacology*; D003596:Cytosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D007555:Isoxazoles / Q000494:pharmacology*; D000077339:Leflunomide; D063065:Organophosphonates / Q000494:pharmacology*; D012333:RNA, Messenger / Q000032:analysis; D012367:RNA, Viral / Q000032:analysis; D012469:Salivary Glands / Q000821:virology*; D013997:Time Factors; D019562:Viral Load; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D000957:Antigens, Viral, Tumor; D000998:Antiviral Agents; D007555:Isoxazoles; D063065:Organophosphonates; D012333:RNA, Messenger; D012367:RNA, Viral; D002939:Ciprofloxacin; D003596:Cytosine; D000077339:Leflunomide; D000077404:Cidofovir
keywords: BKPyV; Cidofovir; Ciprofloxacin; HIV-associated salivary gland disease; Leflunomide; Polyomavirus; Salivary gland cells